盘龙药业：《未来三年股东分红回报规划》明确2025年至2027年分红计划

Core Viewpoint - The company has outlined a shareholder dividend return plan for the years 2025 to 2027, aiming to establish a scientific, sustainable, and stable return mechanism for investors [1] Group 1 - The company emphasizes the importance of shareholder interests and is committed to creating sustainable and reasonable long-term value for investors through prudent operations and a clear return plan [1]